SCM
GILD icon

Stevens Capital Management’s Gilead Sciences GILD Stock Holding History

Stevens Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$802K Buy
+6,346
New +$836K 0.19% 109
2025
Q4 		– Sell
-46,038
Closed -$5.11M – 255
2025
Q3 		$5.11M Buy
+46,038
New +$5.23M 0.68% 35
2024
Q2 		– Sell
-13,196
Closed -$967K – 273
2024
Q1 		$967K Buy
+13,196
New +$1.01M 0.19% 116
2022
Q2 		– Sell
-14,651
Closed -$871K – 174
2022
Q1 		$871K Buy
+14,651
New +$937K 0.19% 120
2021
Q2 		– Sell
-12,055
Closed -$779K – 204
2021
Q1 		$779K Buy
+12,055
New +$777K 0.43% 43
2020
Q3 		– Sell
-61,626
Closed -$4.74M – 153
2020
Q2 		$4.74M Buy
+61,626
New +$4.72M 1.75% 22
2020
Q1 		– Sell
-41,465
Closed -$2.69M – 174
2019
Q4 		$2.69M Sell
41,465
-67,458
-62% -$4.39M 0.25% 108
2019
Q3 		$6.9M Sell
108,923
-48,795
-31% -$3.19M 0.62% 44
2019
Q2 		$10.7M Sell
157,718
-1,747
-1% -$115K 0.48% 46
2019
Q1 		$10.4M Buy
159,465
+50,892
+47% +$3.38M 0.44% 58
2018
Q4 		$6.79M Buy
+108,573
New +$7.59M 0.35% 79
2017
Q3 		– Sell
-50,931
Closed -$3.6M – 927
2017
Q2 		$3.6M Buy
+50,931
New +$3.39M 0.14% 214
2016
Q1 		– Sell
-198,301
Closed -$20.1M – 968
2015
Q4 		$20.1M Buy
198,301
+144,954
+272% +$15.1M 0.79% 17
2015
Q3 		$5.24M Buy
+53,347
New +$5.92M 0.24% 120
2015
Q2 		– Sell
-111,466
Closed -$10.9M – 1098
2015
Q1 		$10.9M Buy
111,466
+90,619
+435% +$9.2M 0.39% 78
2014
Q4 		$1.97M Sell
20,847
-16,406
-44% -$1.7M 0.07% 299
2014
Q3 		$3.97M Buy
+37,253
New +$3.65M 0.12% 214
2014
Q2 		– Sell
-428,724
Closed -$30.4M – 1141
2014
Q1 		$30.4M Buy
428,724
+319,055
+291% +$25M 0.82% 21
2013
Q4 		$8.24M Buy
+109,669
New +$7.64M 0.24% 111
2013
Q3 		– Sell
-264,761
Closed -$13.6M – 1090
2013
Q2 		$13.6M Buy
+264,761
New +$13.8M 0.45% 48

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Stevens Capital Management's GILD Position: Q2 2026 in Review

Stevens Capital Management opened a new position in Gilead Sciences (GILD) in Q2 2026: 6,346 shares worth $802K. The stake represents 0.19% of the portfolio and ranks #109 among its holdings. This is a return to the name: Stevens Capital Management previously reported a position in GILD as recently as Q3 2025.

Stevens Capital Management first reported a position in GILD in Q2 2013 and has held it in 20 quarters since. The position peaked at $30.4M in Q1 2014. 2,279 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Stevens Capital Management held 6,346 shares of Gilead Sciences worth $802K as of Q2 2026.
  • Gilead Sciences was a new Stevens Capital Management position in Q2 2026.
  • Gilead Sciences made up 0.19% of Stevens Capital Management's portfolio in Q2 2026, its #109 holding.
  • Stevens Capital Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 20 quarters since.
  • Stevens Capital Management's Gilead Sciences position peaked at $30.4M in Q1 2014.
  • 2,279 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Stevens Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.